Parkway Life Real Estate Investment (C2PU) AI Stock Analysis

• Market Cap: $2.71B
• Dividend Yield: 3.6%
• Average Volume (3M): 932.25K
• Price to Earnings (P/E): 31.5
• Beta (1Y): 0.38
• Revenue Growth: 2.55%
• EPS Growth: -23.99%
• Country: SG
• Employees: 23
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.06
• Shares Outstanding: 652,453,060
• 10 Day Avg. Volume: 754,280
• 30 Day Avg. Volume: 932,253
• PEG Ratio: -4.11
• Price to Book (P/B): 1.46
• Price to Sales (P/S): 15.87
• P/FCF Ratio: 49.23
• Enterprise Value/Market Cap: 1.31
• Enterprise Value/Revenue: 23.51
• Enterprise Value/Gross Profit: 25.13
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $5.00
• Price Target Upside: 19.67% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3

• Rating: 65 Neutral
• Price Target: S$4.50 ▲(7.66% Upside)

Parkway Life Real Estate Investment's solid financial performance is the most significant factor, supported by strong profitability and effective cash flow management. However, the stock's high valuation and short-term bearish technical indicators weigh down the overall score. The absence of earnings call data and corporate events limits additional insights.

Positive Factors

Strong Profitability

Strong profitability with consistent gross profit margins indicates effective cost management and operational efficiency, supporting long-term financial health.

Cash Flow Management

Strong operating cash flow supports net income, ensuring liquidity and the ability to fund operations and growth initiatives sustainably.

Balanced Leverage Strategy

A moderate debt-to-equity ratio indicates prudent financial management, reducing risk and enhancing financial stability over the long term.

Negative Factors

Revenue Growth Challenges

Negative revenue growth suggests difficulties in expanding market share or increasing sales, which could impact future profitability and market position.

Inconsistent Free Cash Flow

Inconsistent free cash flow growth can limit the company's ability to invest in new opportunities or return capital to shareholders, affecting long-term growth.

EPS Decline

A significant decline in EPS growth indicates potential profitability issues, which could affect investor confidence and the company's ability to reinvest in its business.

Parkway Life Real Estate Investment Business Overview & Revenue Model

Company Description

Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.

How the Company Makes Money

Parkway Life REIT generates revenue primarily through rental income from its portfolio of healthcare properties. The company leases these properties to operators in the healthcare sector, ensuring a steady stream of income. Additionally, the REIT benefits from long-term leases that typically include rental escalations, which help to increase revenue over time. Parkway Life REIT may also engage in property acquisitions and developments, which can provide additional revenue through capital appreciation and enhanced rental yields. Key partnerships with reputable healthcare operators and a focus on high-demand healthcare facilities further contribute to its earnings. The company's revenue is supported by a growing aging population and increased demand for healthcare services, creating a stable environment for its investments.

Parkway Life Real Estate Investment Financial Statement Overview

Summary

Parkway Life Real Estate Investment exhibits a solid financial position characterized by strong profitability and effective cash flow management. While revenue growth has faced recent challenges, the company maintains healthy margins and a balanced leverage strategy, positioning it well within the REIT - Healthcare Facilities industry.

Income Statement

The company demonstrates strong profitability with a consistent gross profit margin. However, while the net profit margin is healthy, recent revenue growth is slightly negative, indicating potential challenges in maintaining top-line growth. EBIT margin is unavailable, but EBITDA margin remains robust, reflecting efficient operations.

Balance Sheet

The balance sheet presents a stable equity ratio, indicating a solid equity position relative to total assets. The debt-to-equity ratio is moderate, reflecting a balanced approach to leverage. Return on equity is strong, suggesting effective use of equity to generate profits.

Cash Flow

Operating cash flow remains strong, supporting net income well. However, free cash flow growth has been inconsistent, with a decline in the most recent year. The free cash flow to net income ratio is solid, indicating good cash conversion from earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	151.16M	144.85M	147.47M	129.97M	120.70M	120.89M
Gross Profit	141.43M	126.74M	124.59M	107.52M	98.43M	99.49M
EBITDA	0.00	113.88M	121.20M	112.14M	100.01M	95.24M
Net Income	83.67M	95.04M	100.47M	41.14M	331.88M	87.22M
Balance Sheet
Total Assets	2.62B	2.55B	2.33B	2.34B	2.35B	2.07B
Cash, Cash Equivalents and Short-Term Investments	49.04M	29.47M	28.50M	40.01M	25.79M	22.66M
Total Debt	927.48M	886.11M	828.47M	851.89M	828.01M	793.65M
Total Liabilities	1.03B	981.20M	919.58M	931.66M	910.43M	883.36M
Stockholders Equity	1.59B	1.57B	1.41B	1.41B	1.43B	1.18B
Cash Flow
Free Cash Flow	0.00	46.68M	77.65M	30.74M	78.17M	85.73M
Operating Cash Flow	0.00	95.79M	108.69M	94.63M	89.86M	90.31M
Investing Cash Flow	0.00	-239.93M	-49.56M	-125.18M	-74.99M	-28.57M
Financing Cash Flow	0.00	147.35M	-67.92M	47.75M	-9.98M	-61.46M

Parkway Life Real Estate Investment Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4.18
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C2PU, the sentiment is Positive. The current price of 4.18 is above the 20-day moving average (MA) of 4.14, above the 50-day MA of 4.17, and above the 200-day MA of 4.00, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 55.45 is Neutral, neither overbought nor oversold. The STOCH value of 75.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C2PU.

Parkway Life Real Estate Investment Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TQ5	70 Outperform	$4.08B	15.52	2.80%	4.29%	19.82%	―
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
C2PU	65 Neutral	$2.71B	31.49	5.49%	3.60%	2.55%	-23.99%
T82U	63 Neutral	$3.85B	―	-0.32%	4.64%	0.01%	-110.22%
9A4U	56 Neutral	S$2.29B	―	-4.88%	6.46%	10.51%	-40.93%
TS0U	54 Neutral	S$1.90B	―	-2.15%	6.12%	-11.65%	-137.98%

Parkway Life Real Estate Investment Corporate Events

Parkway Life REIT to Announce Q3 2025 Business Update

Parkway Life REIT will release its third-quarter business update for the financial period ending 30 September 2025 on 5 November 2025, before trading hours. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning in the real estate investment market.

The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.50 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.

Parkway Life REIT Strengthens Board with New Appointments

Parkway Life Real Estate Investment Trust has announced a significant renewal of its Board of Directors, aimed at strengthening its governance and strategic direction. The appointment of Mr. Robin Hu Yee Cheng as Chairman and Mrs. Eng-Kwok Seat Moey as an Independent Director, along with the continued service of Ms. Theresa Goh Cheng Keow, highlights the company’s commitment to robust governance and sustainable growth. These changes are expected to enhance PLife REIT’s resilience and long-term value creation for its unitholders, reinforcing its reputation in the healthcare real estate investment sector.

The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.50 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.

Parkway Life REIT Issues New Units for Management Fee Payment

Parkway Trust Management Limited, the manager of Parkway Life Real Estate Investment Trust, has announced the issuance of 32,665 new units to itself as part payment for management fees for the second quarter of 2025. This issuance, priced at approximately S$4.11 per unit, increases the total units in circulation to 652,453,073, potentially impacting the trust’s market positioning and stakeholder interests by altering unit distribution and management fee structures.

The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.00 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.

Parkway Life REIT Secures New Facility Agreement for Financial Stability

Parkway Life REIT has entered into a new facility agreement to refinance its existing bank borrowings and support various financial needs, including working capital and business acquisitions. This agreement includes specific conditions that could trigger prepayment obligations, potentially affecting facilities worth approximately S$918 million, highlighting the company’s strategic financial management approach to maintain operational stability.

The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.00 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.

Parkway Life REIT Completes Divestment of Malaysian Property

Parkway Life Real Estate Investment Trust has completed the divestment of its strata units and lots at MOB Specialist Clinics in Kuala Lumpur, Malaysia, to Pantai Medical Centre Sdn. Bhd. This strategic move is part of Parkway Life REIT’s ongoing efforts to optimize its portfolio and enhance value for its stakeholders.

The most recent analyst rating on (SG:C2PU) stock is a Hold with a S$4.00 price target. To see the full list of analyst forecasts on Parkway Life Real Estate Investment stock, see the SG:C2PU Stock Forecast page.

Parkway Life REIT Reports Stable Growth Amid Challenges

Parkway Life Real Estate Investment Trust (REIT) is a Singapore-based unit trust that primarily invests in income-producing real estate and real estate-related assets within the healthcare sector across the Asia-Pacific region. The trust focuses on properties such as hospitals and healthcare facilities, aiming to generate stable returns for its unitholders.